PrimeRFP SCOUT · Federal Contract Recompete Brief

36F79722D0161Temporary PRICE reduction — Amneal Pharmaceuticals of New York, LLC

Amneal Pharmaceuticals of New York, LLC holds $827K across 7 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 1 related award in the incumbent pipeline. Set-aside status: Unrestricted.

Nac Federal Supply Schedule (36F797)
Awarding office
Amneal Pharmaceuticals of New York, LLC
Recipient
—
Estimated value
6505
PSC
Unrestricted
Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number36F79722D0161
Also listed as36F797-22-D-0161
AgencyNac Federal Supply Schedule (36F797)
Awarding officeNac Federal Supply Schedule (36F797)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentAmneal Pharmaceuticals of New York, LLC
UEILVEBAQTPN615
PSC6505
Related solicitation65IB

TEMPORARY PRICE REDUCTION is a federal Unrestricted award for Nac Federal Supply Schedule (36F797) held by Amneal Pharmaceuticals of New York, LLC. Estimated value —. Related solicitation 65IB.

Bonuses end Sept 30

Want the durability read on 36F79722D0161? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Amneal Pharmaceuticals of New York, LLC — $827K obligated across 7 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($827K) · all agencies
Department of Veterans Affairs (VA)$678K · 82%Department of Defense (DOD)$149K · 18%
Open full company profile →

Related awards

Same incumbent
36C26026F0059
PHARMACEUTICAL - XYREM (SODIUM OXYBATE)
$319K
Oct 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36F79722D0161?

36F79722D0161 (Temporary PRICE reduction) is a Nac Federal Supply Schedule (36F797) award with an estimated value of —, currently held by Amneal Pharmaceuticals of New York, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36F797-22-D-0161?

36F797-22-D-0161 is the dashed form of PIID 36F79722D0161 (Temporary PRICE reduction), held by Amneal Pharmaceuticals of New York, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36F79722D0161?

Nac Federal Supply Schedule (36F797) awarded 36F79722D0161 to Amneal Pharmaceuticals of New York, LLC.

Who is the incumbent on 36F79722D0161?

Amneal Pharmaceuticals of New York, LLC is the incumbent with $827K across 7 related awards in SCOUT’s public footprint.

When does Amneal Pharmaceuticals of New York, LLC’s 36F79722D0161 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36F79722D0161? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36F79722D0161